ATE530572T1 - Antigen-cocktails, p35 und verwendungen dafür - Google Patents

Antigen-cocktails, p35 und verwendungen dafür

Info

Publication number
ATE530572T1
ATE530572T1 AT08150599T AT08150599T ATE530572T1 AT E530572 T1 ATE530572 T1 AT E530572T1 AT 08150599 T AT08150599 T AT 08150599T AT 08150599 T AT08150599 T AT 08150599T AT E530572 T1 ATE530572 T1 AT E530572T1
Authority
AT
Austria
Prior art keywords
combinations
antigens
antigen
present
well
Prior art date
Application number
AT08150599T
Other languages
English (en)
Inventor
Gregory Maine
Jeffrey Hunt
Susan Brojanac
Michael Sheu
Linda Chovan
Joan Tyner
Lawrence V Howard
Stephen F Parmley
Jack Remington
Fausto Araujo
Yashuhiro Suzuki
Shuili Li
Original Assignee
Abbott Lab
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Abbott Lab filed Critical Abbott Lab
Application granted granted Critical
Publication of ATE530572T1 publication Critical patent/ATE530572T1/de

Links

Classifications

    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N33/00—Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
    • G01N33/48—Biological material, e.g. blood, urine; Haemocytometers
    • G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
    • G01N33/53—Immunoassay; Biospecific binding assay; Materials therefor
    • G01N33/569—Immunoassay; Biospecific binding assay; Materials therefor for microorganisms, e.g. protozoa, bacteria, viruses
    • G01N33/56905—Protozoa
    • Y—GENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y02—TECHNOLOGIES OR APPLICATIONS FOR MITIGATION OR ADAPTATION AGAINST CLIMATE CHANGE
    • Y02A—TECHNOLOGIES FOR ADAPTATION TO CLIMATE CHANGE
    • Y02A50/00—TECHNOLOGIES FOR ADAPTATION TO CLIMATE CHANGE in human health protection, e.g. against extreme weather
    • Y02A50/30—Against vector-borne diseases, e.g. mosquito-borne, fly-borne, tick-borne or waterborne diseases whose impact is exacerbated by climate change

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Immunology (AREA)
  • Engineering & Computer Science (AREA)
  • Urology & Nephrology (AREA)
  • Chemical & Material Sciences (AREA)
  • Biomedical Technology (AREA)
  • Molecular Biology (AREA)
  • Hematology (AREA)
  • Medicinal Chemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • Biotechnology (AREA)
  • Tropical Medicine & Parasitology (AREA)
  • Virology (AREA)
  • Food Science & Technology (AREA)
  • Microbiology (AREA)
  • Analytical Chemistry (AREA)
  • Cell Biology (AREA)
  • Biochemistry (AREA)
  • Physics & Mathematics (AREA)
  • General Physics & Mathematics (AREA)
  • Pathology (AREA)
  • Peptides Or Proteins (AREA)
  • Preparation Of Compounds By Using Micro-Organisms (AREA)
AT08150599T 1998-05-28 1999-05-27 Antigen-cocktails, p35 und verwendungen dafür ATE530572T1 (de)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US09/086,503 US6329157B1 (en) 1998-05-28 1998-05-28 Antigen cocktails and uses thereof
US09/303,064 US6221619B1 (en) 1998-05-28 1999-04-30 Method of using P35 antigen of toxoplasma gondii in distinguishing acute from chronic toxoplasmosis

Publications (1)

Publication Number Publication Date
ATE530572T1 true ATE530572T1 (de) 2011-11-15

Family

ID=22199009

Family Applications (1)

Application Number Title Priority Date Filing Date
AT08150599T ATE530572T1 (de) 1998-05-28 1999-05-27 Antigen-cocktails, p35 und verwendungen dafür

Country Status (4)

Country Link
US (3) US6329157B1 (de)
EP (1) EP2062913B1 (de)
AT (1) ATE530572T1 (de)
ES (1) ES2373928T3 (de)

Families Citing this family (14)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
ZA958366B (en) * 1994-10-06 1996-04-24 Akzo Nobel Nv New toxoplasma gondii antigens
US6329157B1 (en) * 1998-05-28 2001-12-11 Abbott Laboratories Antigen cocktails and uses thereof
AU2002310099A1 (en) * 2001-05-22 2002-12-03 President And Fellows Of Harvard College Identification of anti-protozoal agents
US7094879B2 (en) * 2002-10-02 2006-08-22 Abbott Laboratories Genetically engineered P30 antigen, improved antigen cocktail, and uses thereof
US20050221507A1 (en) * 2004-03-30 2005-10-06 Intel Corporation Method to detect molecular binding by surface-enhanced Raman spectroscopy
WO2006094665A1 (en) * 2005-03-08 2006-09-14 Kenton Srl Chimeric recombinant antigens of toxoplasma gondii
CN100554965C (zh) * 2005-08-05 2009-10-28 珠海经济特区海泰生物制药有限公司 弓形虫IgM抗体检测试剂及应用
US7432046B2 (en) * 2005-11-02 2008-10-07 Abbott Laboratories Methods for the determination of antibody IgG avidity
KR100803055B1 (ko) * 2006-11-03 2008-02-18 한국과학기술원 구면베어링 조립체의 제조장치 및 그 제조방법
US9610335B2 (en) * 2009-12-10 2017-04-04 Escola Superior Agrária De Coimbra Immunogens, compositions and uses thereof, method for preparing same
KR101219505B1 (ko) * 2010-05-28 2013-01-31 베트올 (주) 고양이 톡소포자충 감염 진단 방법 및 키트
WO2012088125A2 (en) * 2010-12-23 2012-06-28 Immport Therapeutics, Inc. Methods and compositions of protein antigens for the diagnosis and treatment of toxoplasma gondii infections and toxoplasmosis
BR102017005996A2 (pt) * 2017-03-23 2018-10-30 Fundação Oswaldo Cruz método para imunodiagnóstico de toxoplasmose aguda e crônica
KR102808946B1 (ko) * 2023-05-15 2025-05-23 대한민국 재조합단백질 항원을 이용한 다축종 톡소포자충증 감염 진단용 키트

Family Cites Families (11)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DE3940598A1 (de) 1989-12-08 1991-06-13 Behringwerke Ag Toxoplasma gondii-antigene, ihre herstellung und ihre verwendung
US4877726A (en) * 1988-03-02 1989-10-31 Research Institute Of Palo Alto Medical Foundation Method for the detection of acute-phase toxoplasma infection
US5578453A (en) * 1990-08-10 1996-11-26 The Flinders University Of South Australia Cloning and expression of toxoplasma antigens and use of recombinant antigens
CA2049679C (en) 1990-08-24 2005-06-21 Sushil G. Devare Hepatitis c assay utilizing recombinant antigens
KR930702507A (ko) 1990-11-07 1993-09-09 챨스 엠. 브록 C형 간염 바이러스에 대한 모노클로날 항체 및 이의 사용 방법
JPH06510191A (ja) 1991-08-21 1994-11-17 アボツト・ラボラトリーズ Ｎｓ１に対する組換え抗原を利用したｃ型肝炎アッセイ
US5965702A (en) 1991-10-21 1999-10-12 Abbott Laboratories Borrelia burgdorferi antigens and uses thereof
FR2722508B1 (fr) 1994-07-13 1996-10-04 Transgene Sa Cassette d'expression d'une proteine p30 de toxoplasma gondii
ES2108614B1 (es) 1995-07-12 1998-07-16 Oncina Fco Javier Martin Vacunas polimerizadas.
EP0877809A1 (de) 1996-01-26 1998-11-18 Innogenetics N.V. Toxoplasma gondii tg-20 antigen
US6329157B1 (en) * 1998-05-28 2001-12-11 Abbott Laboratories Antigen cocktails and uses thereof

Also Published As

Publication number Publication date
EP2062913A1 (de) 2009-05-27
US20020025542A1 (en) 2002-02-28
ES2373928T3 (es) 2012-02-10
EP2062913B1 (de) 2011-10-26
US6221619B1 (en) 2001-04-24
US6329157B1 (en) 2001-12-11

Similar Documents

Publication Publication Date Title
CY2019029I2 (el) Anti-tnf αντισωματα, συνθεσεις, μεθοδοi και χρησεις
DK1565489T3 (da) Internaliserende antistoffer specifikke for RAAG10-celleoverflademålet
BR9813254A (pt) Antìgeno enterococcus e vacinas
NO870412L (no) Peptider.
IT8320550A0 (it) Procedimento di purificazione peraffinita' in cui si impiegano anticorpi monoclonali.
EP1412538A4 (de) Verfahren zum gleichzeitigen nachweis von hcv-antigenen und hcv-antikörpern
DE59509344D1 (de) Antikörperklassenspezifisches entstörungsreagenz
CA2049679A1 (en) Hepatitis c assay utilizing recombinant antigens
ATE191792T1 (de) Verfahren zur detektion von hepatitis c
ATE430757T1 (de) Gentechnisch hergestelltes p30-antigen, verbesserter antigen-cocktail und verwendungen davon
IT1302026B1 (it) Materiali immunologici e metodi per la rivelazione di diidropirimidinadeidrogenasi.
ATE171473T1 (de) Humanisierte monoklonale antikörper gegen humanes interleukin - 4
WO1999061906A3 (en) Toxoplasma gondii antigens, p35, and uses thereof
DE60324003D1 (en) Hcv-test
NO20005670L (no) Proteiner fra Moraxella Catarrhalis
ITRM910385A1 (it) Vaccini utilizzanti eritrociti come veicoli di antigeni
DE69929468D1 (de) VERBESSERTE SPEZIFITÄT IN DER DETEKTION DER ANTI-RUBELLA IgM ANTIKÖRPER
EP1268749A4 (de) Diagnostische reagenzien und methoden für antikörper gegen hepatitis b oberflächenantigen und für antikörper gegen hepatitis b virus
EP1071325A4 (de) Zusammensetzungen und verfahren für eine antigenspezifische impfung
DK0599913T3 (da) Monoklonale antistoffer mod formodet hepatitis C-virus NS5-proteiner og anvendelsesmetoder af samme
BR9801272A (pt) Método de detecção de anticorpos e/ou antígenos
WO2003050268A3 (en) Enhancement of the immune response using cd36-binding domain
IT8821547A0 (it) Metodo immunologico per la determinazione di anticorpi anti antigeni di microorganismi, mediante anticorpi antiidiotipo e mezzi adatti allo scopo.
IL127249A0 (en) Human monoclonal antibodies to the hepatitis b surface antigen
FI950253L (fi) Fimbria-antigeenejä, -vasta-aineita, -osoitusmenetelmiä ja -rokotteita

Legal Events

Date Code Title Description
RER Ceased as to paragraph 5 lit. 3 law introducing patent treaties